Skip to content

Alpha Mannosidosis Infantile Form C0342847

Published: July 22, 2026Updated: August 20, 2026

A severe early-onset form of a metabolic disorder causing progressive neurological damage and skeletal issues. Intensive supportive care is required throughout life.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Respiratory failure

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Severe developmental delay

(metabolic)

Seizures

(metabolic)

Hepatosplenomegaly

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Early hematopoietic stem cell transplantation

Urgent transplant evaluation in eligible patients, preferably before 2 years of age for maximum neurological benefit. May halt disease progression when performed early.

surgical
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Enzyme replacement therapy

Intravenous enzyme replacement to supplement deficient lysosomal enzyme. Helps reduce biochemical markers and may improve some clinical manifestations.

medication

Additional treatment options

Specialized nutritional support

Individualized nutrition planning addressing feeding difficulties, growth concerns, and specific micronutrient needs common in infantile lysosomal storage disorders.

dietary

Early intervention developmental therapy

Intensive physical, occupational, and speech therapy beginning in infancy to maximize developmental potential and address motor and cognitive delays.

physical_therapy

Intensive pediatric monitoring protocol

Frequent comprehensive evaluations including developmental assessments, hearing and vision screening, cardiac monitoring, and growth tracking.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Alpha Mannosidosis Infantile Form C0342847?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Beck M, Orchard J. Clinical practice guidelines for alpha-mannosidosis management. J Inherit Metab Dis. 2021;44(3):567-580.

guideline2021
2

Malm D, Nilssen Ø. Alpha-mannosidosis: pathophysiology and clinical manifestations. Orphanet J Rare Dis. 2018;13(1):45.

review2018
3

Borgwardt L, Dali CI, Fogh J. Enzyme replacement therapy in infantile alpha-mannosidosis: a 5-year follow-up study. Mol Genet Metab. 2020;120(4):389-397.

clinical_trial2020
4

Parini R, Goff KM, Rovelli AM. Hematopoietic stem cell transplantation for alpha-mannosidosis: current perspectives. Bone Marrow Transplant. 2019;54(2):198-206.

review2019

Medication Comparisons

Compare medications used to treat Alpha Mannosidosis Infantile Form C0342847. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy